If you are curious whether glutathione IV therapy is right for your detox, skin, or energy goals, Jennifer Jose-Cappola, MD is here to answer your questions and help you make an informed decision
Plus, your provider is available between appointments via messaging if you have questions or need support
We are not aware of any reason to discontinue the drug other than side effects
Miles Fisher Address for correspondence: Professor Miles Fisher Department of Diabetes, Endocrinology & Clinical Pharmacology, Glasgow Royal Infirmary, 84 Castle Street, Glasgow G4 0SF, UK E-mail: [email protected] SUSTAIN-6 (Trial to Evaluate Cardiovascular and Other Long-term Outcomes with Semaglutide in Subjects with Type 2 Diabetes) was a pre-licensing FDA-mandated cardiovascular outcome trial with subcutaneous semaglutide and was the first completed trial with a once-weekly glucagon-like peptide-1 receptor agonist
This will differ by geography, largely reflecting the obesity profiles of different markets, and by age, sex, and access to the drugs
PMID: 34859235
